I am delighted to announce that our next NoSilverBullet Zoom webinar will be taking place at 7.30pm London time on Monday, the 11th of November.
Dr Laurie Mischley, ND PhD MPH, will be talking to us about “Rebranding Parkinson’s - a new patient-centred, evidence-based approach".
It’s time to reframe our thinking and take a new approach: Despite 200+ years of effort, we do not have a system to predict, prevent, halt, or reverse Parkinson’s. Dr Mischley will explore the notion that the problem lies in the lens through which we’ve been viewing it, the approaches we’ve been taking, and the assumptions we’ve been making.
Please use the Eventbrite link below to register for this event:
eventbrite.co.uk/e/10523118...
Please visit our website if you want to know more about us:
+++
“Rebranding" Parkinson’s: It’s time to reframe our thinking and take a new approach: Despite 200+ years of effort, we do not have a system to predict, prevent, halt, or reverse Parkinson’s. Dr Mischley will explore the notion that the problem lies in the lens through which we’ve been viewing it, the approaches we’ve been taking, and the assumptions we’ve been making.
- Provider bias: Dopamine has been a distraction and obstacle for disease-modification research. Subjective measures are better in early PD.
- Industry bias.
- Floor effects for crude measurement systems: Phase 3 studies keep failing because the tools we’ve been using to determine severity aren’t sensitive in newly-diagnosed people in disease-modification research studies. Study designs are flawed. People who enrol in studies are probably not the same as the global population.
- Providers’ opinion that Parkinson’s is “irreversible and progressive” is outdated and contributes to the problem.
- "What works” and “what providers know how to teach” and “what insurance will pay for” are often not aligned.
- The systems - and access to the systems - play a role in determining outcomes.
- We already have tools to make Parkinson’s preventable and reversible that we’re not using.
This revised patient-centred, evidence-based pragmatic paradigm will include education, symptom tracking, goal-setting, counselling, laboratory tests to screen for nutritional deficiencies, counselling regarding diet, daily physical activity, social health, and strategies to encourage financial stability.
+++
Bio: Laurie Mischley, ND PhD MPH studied naturopathic medicine (ND) at Bastyr University and epidemiology (MPH) and nutritional sciences (PhD) at the University of Washington and she maintains appointments at both Universities. Her work is focused on identifying the nutritional requirements unique to individuals with Parkinson’s Disease (PD) and has published on coenzyme Q10, lithium, NAD+, and glutathione deficiency (lauriemischley.com). She is Principal Investigator of the Modifiable Variables in Parkinsonism (MVP) Study (MVP-study.com), which is attempting to describe why some people with PD progress slower than others. She is working on ways to study, package and deliver evidence-based lifestyle modification as a therapeutic strategy. She founded the Parkinson Center for Pragmatic Research (parkinson-cpr.com) and the canine scent-based PD screening tool, ParK-9 (Park-9.com), developed a patient-reported outcome measure to assess PD severity (PD-symptoms.com), built the Parkinson Symptom Tracking (PRO-PD) App, and is instructor of the online series, Parkinson School (Parkinson-School.com). Dr. Mischley maintains a small clinical practice at Seattle Integrative Medicine focused on nutrition and neurological health of patients with Parkinsonism.
Nutrition and Parkinsons
ATP and NAD+ Deficiency in Parkinson’s Disease
New to Parkinson's? Or not new, but tired of taking supplement that don't improve Parkinson's cardinal symptoms of bradykinesia and tremor?
Effect of Melatonin Administration on Mitochondrial Activity and Oxidative Stress Markers in Patients with Parkinson’s Disease 2021
